• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服或阴道用奥硝唑、塞克硝唑和甲硝唑治疗细菌性阴道病。

Treatment of bacterial vaginosis with oral or vaginal ornidazole, secnidazole and metronidazole.

作者信息

Saraçoğlu F, Göl K, Sahin I, Türkkani B, Atalay C, Oztopçu C

机构信息

Department of Obstetrics and Gynecology, Numune Hospital, Ankara, Turkey.

出版信息

Int J Gynaecol Obstet. 1998 Jul;62(1):59-61. doi: 10.1016/s0020-7292(98)00029-0.

DOI:10.1016/s0020-7292(98)00029-0
PMID:9722127
Abstract

OBJECTIVE

To evaluate the clinical efficacy and tolerance of oral or vaginal ornidazole, secnidazole and metronidazole or their combinations for treatment of bacterial vaginosis.

METHOD

In an open, randomized, prospective study, 152 patients with bacterial vaginosis according to Amsel's criteria were included into the study. The patients were divided into eight groups: (1) oral ornidazole 2 x 500 mg/day for 5 days; (2) vaginal ornidazole 500 mg/day for 5 days; (3) oral and vaginal ornidazole for 5 days; (4) oral secnidazole 2 g in a single dose; (5) oral secnidazole 2 g in a single dose and vaginal ornidazole 500 mg/day for 5 days; (6) oral secnidazole 2 g in a single dose and vaginal metronidazole 2 x 500 mg/day for 7 days; (7) oral ornidazole 2 x 500 mg/day for 5 days and vaginal metronidazole 2 x 500 mg/day for 7 days; and (8) vaginal metronidazole 2 x 500 mg/day for 7 days. None of the partners received any treatment.

RESULT

We found a 100% cure rate in both oral and vaginal ornidazole and oral secnidazole-vaginal metronidazole groups.

CONCLUSION

Vaginal treatments including ornidazole and metronidazole are not as effective as both oral and vaginal drug combinations.

摘要

目的

评估口服或阴道用奥硝唑、塞克硝唑和甲硝唑及其联合用药治疗细菌性阴道病的临床疗效和耐受性。

方法

在一项开放、随机、前瞻性研究中,根据阿姆塞尔标准纳入152例细菌性阴道病患者。患者被分为八组:(1)口服奥硝唑,每日2次,每次500mg,共5天;(2)阴道用奥硝唑,每日500mg,共5天;(3)口服和阴道用奥硝唑,共5天;(4)口服塞克硝唑,单次剂量2g;(5)口服塞克硝唑单次剂量2g,同时阴道用奥硝唑,每日500mg,共5天;(6)口服塞克硝唑单次剂量2g,同时阴道用甲硝唑,每日2次,每次500mg,共7天;(7)口服奥硝唑,每日2次,每次500mg,共5天,同时阴道用甲硝唑,每日2次,每次500mg,共7天;(8)阴道用甲硝唑,每日2次,每次500mg,共7天。所有性伴侣均未接受任何治疗。

结果

我们发现口服和阴道用奥硝唑组以及口服塞克硝唑 - 阴道用甲硝唑组的治愈率均为100%。

结论

包括奥硝唑和甲硝唑在内的阴道用药治疗不如口服与阴道联合用药有效。

相似文献

1
Treatment of bacterial vaginosis with oral or vaginal ornidazole, secnidazole and metronidazole.口服或阴道用奥硝唑、塞克硝唑和甲硝唑治疗细菌性阴道病。
Int J Gynaecol Obstet. 1998 Jul;62(1):59-61. doi: 10.1016/s0020-7292(98)00029-0.
2
[Efficacy of 5-nitroimidazole derivatives in treatment of bacterial vaginosis].5-硝基咪唑衍生物治疗细菌性阴道病的疗效
Zhonghua Yi Xue Za Zhi. 2008 Aug 12;88(31):2201-3.
3
Secnidazole for treatment of bacterial vaginosis: a systematic review.甲硝唑治疗细菌性阴道病的系统评价。
BMC Womens Health. 2019 Oct 21;19(1):121. doi: 10.1186/s12905-019-0822-2.
4
A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis.一项关于单次口服2克塞克硝唑治疗细菌性阴道病女性有效性和安全性的3期双盲安慰剂对照研究。
Am J Obstet Gynecol. 2017 Dec;217(6):678.e1-678.e9. doi: 10.1016/j.ajog.2017.08.017. Epub 2017 Sep 1.
5
Efficacy and safety of single dose of oral secnidazole 2 g in treatment of bacterial vaginosis: A systematic review and meta-analysis.单次口服 2 克塞克硝唑治疗细菌性阴道病的疗效和安全性:系统评价和荟萃分析。
Eur J Obstet Gynecol Reprod Biol. 2019 Jul;238:125-131. doi: 10.1016/j.ejogrb.2019.05.013. Epub 2019 May 14.
6
A comparative study of oral single dose of metronidazole, tinidazole, secnidazole and ornidazole in bacterial vaginosis.口服单次剂量甲硝唑、替硝唑、塞克硝唑和奥硝唑治疗细菌性阴道病的比较研究。
Indian J Pharmacol. 2012 Mar;44(2):243-5. doi: 10.4103/0253-7613.93859.
7
Single hydrogen peroxide vaginal douching versus single-dose oral metronidazole for the treatment of bacterial vaginosis: a randomized controlled trial.单剂量过氧化氢阴道灌洗与单剂量口服甲硝唑治疗细菌性阴道病的随机对照试验
J Med Assoc Thai. 2003 Jun;86 Suppl 2:S379-84.
8
Secnidazole Treatment of Bacterial Vaginosis: A Randomized Controlled Trial.塞克硝唑治疗细菌性阴道病:一项随机对照试验。
Obstet Gynecol. 2017 Aug;130(2):379-386. doi: 10.1097/AOG.0000000000002135.
9
Treatment of bacterial vaginosis: a multicenter, double-blind, double-dummy, randomised phase III study comparing secnidazole and metronidazole.细菌性阴道病的治疗:一项比较塞克硝唑和甲硝唑的多中心、双盲、双模拟、随机III期研究。
Infect Dis Obstet Gynecol. 2010;2010. doi: 10.1155/2010/705692. Epub 2010 Sep 15.
10
A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 g for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial Vaginosis.一项评估单剂量 2g 司泊硝唑用于治疗细菌性阴道病的女性和月经初潮后青少年女性的安全性的 3 期、多中心、前瞻性、开放标签研究。
J Womens Health (Larchmt). 2018 Apr;27(4):492-497. doi: 10.1089/jwh.2017.6500. Epub 2018 Jan 11.

引用本文的文献

1
Efficacy and safety of different drugs for the treatment of bacterial vaginosis: a systematic review and network meta-analysis.不同药物治疗细菌性阴道病的疗效和安全性:系统评价和网络荟萃分析。
Front Cell Infect Microbiol. 2024 Oct 11;14:1402346. doi: 10.3389/fcimb.2024.1402346. eCollection 2024.
2
Secnidazole for treatment of bacterial vaginosis: a systematic review.甲硝唑治疗细菌性阴道病的系统评价。
BMC Womens Health. 2019 Oct 21;19(1):121. doi: 10.1186/s12905-019-0822-2.
3
Treatment of bacterial vaginosis: a multicenter, double-blind, double-dummy, randomised phase III study comparing secnidazole and metronidazole.
细菌性阴道病的治疗:一项比较塞克硝唑和甲硝唑的多中心、双盲、双模拟、随机III期研究。
Infect Dis Obstet Gynecol. 2010;2010. doi: 10.1155/2010/705692. Epub 2010 Sep 15.
4
Study on poly(vinyl alcohol)/carboxymethyl-chitosan blend film as local drug delivery system.聚乙烯醇/羧甲基壳聚糖共混膜作为局部给药系统的研究
J Mater Sci Mater Med. 2007 Jun;18(6):1125-33. doi: 10.1007/s10856-007-0159-5. Epub 2007 Feb 1.